Autochecked users, Comment administrators, Editors, Interface administrators, Reviewers, Suppressors, Administrators, Widget editors
1,876
edits
Changes
no edit summary
==Primary Author(s)*==
==Primary Author(s)*==
==Cancer Category/Type==
==Cancer Category/Type==
[[Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
[[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
==Cancer Sub-Classification / Subtype==
==Cancer Sub-Classification / Subtype==
==Epidemiology / Prevalence==
==Epidemiology / Prevalence==
*Occurs in middle-aged and elderly individuals
*Occurs in middle-aged and elderly individuals<ref name=":0">{{Cite journal|last=L|first=de Leval|last2=C|first2=Gisselbrecht|last3=P|first3=Gaulard|date=2010|title=Advances in the understanding and management of angioimmunoblastic T-cell lymphoma|url=https://pubmed.ncbi.nlm.nih.gov/19961485/|language=en|pmid=19961485}}</ref>
*Males >> Females
*Males >> Females<ref name=":0" />
*One of the most common specific subtypes of PTCL
*One of the most common specific subtypes of PTCL<ref>{{Cite journal|last=M|first=Vences|last2=Jm|first2=Guayasamin|last3=A|first3=Miralles|last4=I|first4=De la Riva|date=2013|title=To name or not to name: Criteria to promote economy of change in Linnaean classification schemes|url=https://pubmed.ncbi.nlm.nih.gov/26042291/|language=en|pmid=26042291}}</ref><ref>{{Cite journal|last=T|first=Rüdiger|last2=Dd|first2=Weisenburger|last3=Jr|first3=Anderson|last4=Jo|first4=Armitage|last5=J|first5=Diebold|last6=Ka|first6=MacLennan|last7=Bn|first7=Nathwani|last8=F|first8=Ullrich|last9=Hk|first9=Müller-Hermelink|date=2002|title=Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project|url=https://pubmed.ncbi.nlm.nih.gov/11863096/|language=en|pmid=11863096}}</ref><ref>{{Cite journal|last=J|first=Vose|last2=J|first2=Armitage|last3=D|first3=Weisenburger|date=2008|title=International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes|url=https://pubmed.ncbi.nlm.nih.gov/18626005/|language=en|pmid=18626005}}</ref>
**15-30% of non-cutaneous T-cell lymphomas
**15-30% of non-cutaneous T-cell lymphomas
**1-2% of all non-Hodgkin lymphomas
**1-2% of all non-Hodgkin lymphomas
==Clinical Features<small></small>==
==Clinical Features<small><ref>{{Cite journal|last=A|first=Dogan|last2=Ad|first2=Attygalle|last3=C|first3=Kyriakou|date=2003|title=Angioimmunoblastic T-cell lymphoma|url=https://pubmed.ncbi.nlm.nih.gov/12780782/|language=en|pmid=12780782}}</ref><ref>{{Cite journal|last=F|first=Lachenal|last2=F|first2=Berger|last3=H|first3=Ghesquières|last4=P|first4=Biron|last5=A|first5=Hot|last6=E|first6=Callet-Bauchu|last7=C|first7=Chassagne|last8=B|first8=Coiffier|last9=I|first9=Durieu|date=2007|title=Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients|url=https://pubmed.ncbi.nlm.nih.gov/17873758/|language=en|pmid=17873758}}</ref><ref>{{Cite journal|last=N|first=Mourad|last2=N|first2=Mounier|last3=J|first3=Brière|last4=E|first4=Raffoux|last5=A|first5=Delmer|last6=A|first6=Feller|last7=Cj|first7=Meijer|last8=Jf|first8=Emile|last9=R|first9=Bouabdallah|date=2008|title=Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials|url=https://pubmed.ncbi.nlm.nih.gov/18292286/|language=en|doi=10.1182/blood-2007-08-105759|pmc=PMC2343588|pmid=18292286}}</ref><ref>{{Cite journal|last=W|first=Siegert|last2=C|first2=Nerl|last3=A|first3=Agthe|last4=M|first4=Engelhard|last5=G|first5=Brittinger|last6=M|first6=Tiemann|last7=K|first7=Lennert|last8=D|first8=Huhn|date=1995|title=Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group|url=https://pubmed.ncbi.nlm.nih.gov/8664186/|language=en|pmid=8664186}}</ref></small>==
'''Sign and Symptoms'''
'''Sign and Symptoms'''
==Chromosomal Rearrangements (Gene Fusions)==
==Chromosomal Rearrangements (Gene Fusions)==
==Characteristic Chromosomal Aberrations / Patterns==
==Characteristic Chromosomal Aberrations / Patterns==
==Links==
==Links==
[[Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
[[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
==References==
==References==